Related Experiment Video

Updated: Jun 25, 2026

Preparation and Characterization of Novel HDL-mimicking Nanoparticles for Nerve Growth Factor Encapsulation
08:24

Preparation and Characterization of Novel HDL-mimicking Nanoparticles for Nerve Growth Factor Encapsulation

Published on: May 22, 2017

Novel therapies for increasing serum levels of HDL

Peter P Toth1

  • 1Sterling Rock Falls Clinic, Ltd., 101 East Miller Road, Sterling, IL 61081, USA. peter.toth@srfc.com

Endocrinology and Metabolism Clinics of North America
|February 17, 2009
PubMed

Insights

High-density lipoprotein cholesterol (HDL-C) offers protection against coronary heart disease (CHD). New treatments aim to increase HDL-C and particle numbers to lower residual risk in patients with or at risk for CHD.

Area of Science:

  • Cardiovascular Science
  • Lipid Metabolism
  • Pharmacology

Background:

  • Elevated high-density lipoprotein cholesterol (HDL-C) is investigated for its protective effects against coronary heart disease (CHD).
  • HDL possesses anti-atherogenic properties, including modulation of inflammation, oxidation, and thrombosis.
  • HDL facilitates reverse cholesterol transport, a key process for lipid clearance.

Purpose of the Study:

  • To discuss the development of novel therapeutic strategies.
  • To explore treatments targeting increased HDL-C levels and particle counts.
  • To reduce residual cardiovascular risk in patients susceptible to CHD.

Main Methods:

  • Review of current research on HDL-C and CHD.
  • Discussion of emerging therapeutic agents.
  • Analysis of strategies to enhance HDL functionality.

Main Results:

  • Numerous therapeutic agents are in development to modulate HDL-C and its function.
  • These agents aim to increase HDL-C levels and HDL particle numbers.
  • The goal is to mitigate residual risk in patients at risk for CHD.

Conclusions:

  • Targeting HDL-C and HDL functionality represents a promising approach.
  • New treatments may offer significant benefits for patients with cardiovascular risk.
  • Further research is crucial to validate the efficacy of these developing therapies.

More Related Videos

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...